Quarterly report pursuant to Section 13 or 15(d)

Fixed Assets

v3.10.0.1
Fixed Assets
6 Months Ended
Dec. 31, 2018
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment Disclosure [Text Block]
Note 4. Fixed Assets
 
The following is a summary of fixed assets and accumulated depreciation:
 
 
 
Useful
 
December 31,
 
 
June 30,
 
 
 
Life
 
2018
 
 
2018
 
Furniture and fixtures
 
5 - 7 years
 
$
-
 
 
$
118,450
 
Lab equipment
 
3 - 15 years
 
 
-
 
 
 
738,415
 
Leasehold Improvements
 
5 - 7 years
 
 
-
 
 
 
29,296
 
Total fixed assets
 
 
 
 
-
 
 
 
886,161
 
Less accumulated depreciation and amortization
 
 
 
 
-
 
 
 
(517,787
)
Net fixed assets
 
 
 
$
-
 
 
$
368,374
 
 
Depreciation and amortization expense amounted to $12,664 and $266,781 for the three months ended December 31, 2018 and 2017, respectively. Depreciation and amortization expense amounted to $38,832 and $533,394 for the six months ended December 31, 2018 and 2017, respectively
 
For the three months ended September 30, 2018, the Company completed sales of furniture, fixtures, and laboratory equipment for proceeds of $187,139. This resulted in the Company recording a gain on sale of fixed assets of $22,852. For the three months ended December 31, 2018, the Company completed an additional sale of furniture and fixtures for proceeds of $8,000. This sale resulted in the Company recording a loss on sale of fixed assets of $45,679.
 
Additionally, in December 2018 the Company vacated its leased office and laboratory space in Louisville, Colorado, resulting in an impairment charge of $33,039 related to leasehold improvements, laboratory equipment, furniture and fixtures that the Company is not expected to receive any further economic benefit from. As of December 31, 2018, the Company classified the remaining laboratory equipment with an estimated fair value of $72,537 as assets held for sale. In January 2019, the Company sold this equipment and collected the net proceeds of $
72,537
.